Journal
PHYTOCHEMISTRY LETTERS
Volume 7, Issue -, Pages 77-84Publisher
ELSEVIER
DOI: 10.1016/j.phytol.2013.10.005
Keywords
Portulacerebroside A; Liver cancer; Apoptosis; Mitochondria; Caspase
Categories
Funding
- National Natural Science Foundation of China [81102774]
Ask authors/readers for more resources
Portulacerebroside A (PCA) is a novel cerebroside compound isolated from Portulaca oleracea L. The present results showed that PCA significantly inhibited cell viability time-and dose-dependently, elicited chromatin aggregation and fragmented nuclei, and enhanced the percentage of apoptotic cells. Furthermore PCA remarkably increased the protein phosphorylation of p38 MAPK and JNK, disrupted mitochondrial membrane penetrability, and triggered the release of mitochondrial cytochrome c and AIF to cytosol. Treatment with PCA also evidently activated caspase-9 and caspase-3 but not caspase-8. These results suggest that PCA-induced apoptosis is associated with activation of the p38 MAPK-and JNK-triggered mitochondrial death pathway. PCA possibly has the high potential for clinical applications in treating liver cancer and improving cancer chemotherapy. (C) 2013 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available